Defining the impact and contribution of steroids in patients receiving whole-brain irradiation for cerebral metastases

Clinical Oncology

Volumn 16, Issue 5, 2004, Pages 339-344

  Millar, Barbara ann M ^a,b   Bezjak, A ^a,b   Tsao, M ^a,c   Sturdza, A ^a   Laperriere, N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Brain neoplasms; Radiotherapy; Secondary neoplasms steroids

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; STEROID;

ANKLE EDEMA; ARTICLE; BODY WEIGHT DISORDER; BRAIN METASTASIS; BRAIN RADIATION; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG USE; HUMAN; MEDICAL LITERATURE; MOON FACE; MUSCLE WEAKNESS; MYOPATHY; NEUROLOGIC EXAMINATION; OUTCOMES RESEARCH; PERIPHERAL EDEMA; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; STEROID THERAPY; WEIGHT GAIN;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; RANDOMIZED CONTROLLED TRIALS; STEROIDS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 3242771435     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.03.015     Document Type: Article

References (33)

1. Tsao M.N. Sultanem K. Chiu D. et al. Supportive care management of brain metastases: what is known and what we need to know. Conference proceedings of the National Cancer Institute of Canada (NCIC) Workshop on Symptom Control in Radiation Oncology Clin Oncol 15 2003 429-434
2. Gerrard G.E. Prestwich R.J. Edwards A. et al. Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features Clin Oncol 15 2003 422-428
3. Tsao M.N. Chow E. Wong R. Rakovitch E. Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases (Protocol for a Cochrane Review) The Cochrane Library, Issue 4 2003 John Wiley & Sons, Ltd. Chichester, UK
4. Bezjak A. Adam J. Barton R. et al. Symptom response after palliative radiotherapy for patients with brain metastases Eur J Cancer 38 2002 487-496
5. Borgelt B. Gelber R. Kramer S. et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 6 1980 1-9
6. Borgelt B. Gelber R. Larson M. Hendrickson F. Griffin T. Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 7 1981 1633-1638
7. Chatani M. Teshima T. Hata K. Inque T. Suzuki T. Whole brain irradiation for metastases from lung cancer. A Clinical investigation Acta Radiol Oncol 24 1985 311-314
8. Chatani M. Matayoshi Y. Masaki N. Inoue T. Radiation therapy for brain metastases from lung carcinoma Strahlenther Onkol 170 1994 155-161
9. Haie-Meder C.P. Laplanche A. Lagrange J.L. Tuchais C. Nogues C. Arriagada R. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases Radiother Oncol 26 1993 111-116
10. Priestman T.J. Dunn J. Brada M. Rampling R. Baker P.J. Final results of the Royal College of Radiologists trial comparing two different radiotherapy schedules in the treatment of cerebral metastases Clin Oncol 8 1996 308-315
11. Harwood A.R. Simpson W.J. Radiation therapy of cerebral metastases: a randomized prospective clinical trial Int J Radiat Oncol Biol Phys 2 1977 1091-1094
12. Kurtz J.M. Gelber R. Brady L.W. Carella R.J. Cooper J.S. The palliation of brain metastases in a favorable patient population: randomized clinical trial by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 7 1981 891-895
13. Murray K.J. Scott C. Greenberg H.M. et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104 Int J Radiat Oncol Biol Phys 39 1997 571-574
14. De Angelis L.M. Currie V.E. Kim J.H. et al. The combined use of radiation therapy and lonidamine in the treatment of brain metastases J Neurooncol 7 1989 241-247
15. Shaw E. Scott C. Suh J. et al. RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database J Clin Oncol 21 2003 2364-2371
16. Phillips T.L. Scott C.B. Leibel S.A. Rotman M. Weigensberg I.J. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05 Int J Radiat Oncol Biol Phys 33 1995 339-348
17. Komarnicky L.T. Phillips T.L. Martz K. Asbell S. Isaacson S. Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916) Int J Radiat Oncol Biol Phys 20 1991 53-58
18. Eyre H.J. Ohlesen J.D. Frank J. et al. Randomized trial of radiotherapy versus radiotherapy and metronidazole for the treatment of metastatic cancer to brain. A Southwest Oncology Group Study J Neurooncol 2 1984 325-330
19. Mehta M.P. Rodrigus P. Terhaard C.H.J. et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases J Clin Oncol 21 2003 2529-2536
20. Horton J.B.D. Olson K. The management of metastases to the brain by irradiation and corticosteroids Am J Roentgenol Radium Ther Nucl Med 3 1971 334-336
21. Antonadou D. Paraskevaidis M. Sarris G. et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 20 2002 3644-3650
22. Robinet G. Thomas P. Breton J.L. et al. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1 Ann Oncol 12 2001 59-67
23. Postmus P.E. Haaxma-Reiche H. Smit E.F. et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy: a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group J Clin Oncol 18 2000 3400-3408
24. Ushio Y. Arita N. Hayakawa T. et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study Neurosurgery 28 1991 201-205
25. Kondziolka D. Patel A. Lunsford L.D. Kassam A. Flickinger J.C. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metasases Int J Radiat Oncol Biol Phys 45 1999 427-434
26. Harwood A.R. Simpson W.J. Radiation therapy of cerebral metastases: a randomized prospective clinical trial Int J Radiat Oncol Biol Phys 2 1977 1091-1094
27. Vecht C.J. Hovestadt A. Verbiest H.B. van Vliet J.J. van Putten W.L. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day Neurology 44 1994 675-680
28. Hempen C. Weiss E. Hess C.F. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects? Support Care Cancer 10 2002 322-328
29. Postmus P.E. Smit E.F. Haaxma-Reiche H. et al. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group J Clin Oncol 13 1995 660-665
30. Lagerwaard F.J. Levendag P.C. Nowak P.J. Eijkenboom W.M. Hanssens P.E. Schmitz P.I. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients Int J Radiat Oncol Biol Phys 43 1999 795-803
31. Macdonald D.R. Cascino T.L. Schold S.C. Jr. Cairncross J.G. Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1990 1277-1280
32. Perry J.R. Cairncross J.G. Glioma therapies: how to tell which work? J Clin Oncol 21 2003 3547-3549
33. Chow E. Wu J.S. Hoskin P. Coia L.R. Bentzen S.M. Blitzer P.H. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases [see comment] Radiother Oncol 64 2002 275-280